Patterns of prescription and discontinuation of glucagon like peptide-1 receptor agonists among patients with irritable bowel syndrome
Our findings highlight the importance of tailoring therapy based on drug-specific and patient-related factors to optimize GLP-1RA use in IBS.
Authors
- Misha Gautam (ORCID: https://orcid.org/0000-0002-3826-2132)
Institutions
- University of Missouri–Kansas City (US)
Publication Details
- Journal
- Annals of Gastroenterology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.20524/aog.2025.0971
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Missouri